查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1571749

人工呼吸器/麻醉面罩市场规模、份额、趋势分析报告：按面罩类型、按应用、按地区、细分市场预测，2024-2030 年

Artificial Ventilation And Anesthesia Masks Market Size, Share & Trends Analysis Report By Mask Type (Disposable, Reusable), By Application (Operating Rooms, ICU, Emergency Rooms, Homecare), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格
简介目录

人工呼吸器和麻醉面罩市场的成长和趋势：

Grand View Research 的最新报告显示，到 2030 年，全球人工呼吸器和麻醉面罩市场预计将达到 33 亿美元。预计2024年至2030年该市场将以5.1%的复合年增长率成长。市场成长的关键因素包括手术和急救程序数量的增加，以及对无需取下氧气罩即可进行插管过程的新型产品的需求增加。目标疾病的增加预计将直接影响手术室、急诊室和加护治疗室的数量，从而推动预测期内呼吸面罩的使用率。

老年人口的增加是多种疾病盛行率增加的主要因素。此外，睡眠呼吸中止症盛行率的增加是预测期内麻醉和呼吸面罩的最重要驱动因素之一。

根据美国国家睡眠基金会2012年公布的统计数据，约有4000万美国人受到慢性睡眠障碍的影响。此外，这些患者前往急诊室和加护病房就诊的风险较高，预计未来七年对呼吸面罩的需求将会增加。

根据市场动态，该领域的各个公司在产品规格和价格上竞争。製造中使用的技术、产品品质和患者舒适度是影响这些产品使用的关键变数。医疗保健提供者评估患者的风险并决定是否使用有创通气或非侵入性通气。在事故、创伤、肺衰竭和其他紧急情况下使用非侵入性口罩是推动这些产品使用增加的一个主要因素。

市场按应用细分为手术室、加护病房、急诊室、牙科和居家医疗。 2014年，手术室在低风险手术中所占比例最大，超过58%，预计在未来七年仍将是最大的部分。保险渗透率的上升、医院和牙科中心数量的增加，以开拓新兴国家未满足的高需求，是预计推高手术数量的主要因素，因此预计这些因素将增加预测期内对呼吸面罩的需求。增加需求。

人工呼吸器和麻醉面罩市场报告要点

  • 2023年，一次性口罩的销售份额最大，为68.0%。一次性口罩在医疗产业的优势在于其成本效益、使用者便利性、感染风险降低以及符合法律要求。
  • 手术室应用领域在 2023 年占据市场主导地位，销售份额为 32.0%。手术室拥有最先进的呼吸系统和麻醉设备，可精确控制空气循环量和麻醉剂浓度。
  • 预计可重复使用口罩在预测期内将大幅成长，复合年增长率为 4.6%。可重复使用的口罩可以清洗和重复使用，减少废弃物并最大限度地降低成本，使其成为医院经济高效的解决方案。
  • 2023年，北美人工呼吸器/麻醉面罩市场主导全球人工呼吸器/麻醉面罩市场，销售份额为36.1%。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章人工呼吸器和麻醉面罩市场变数、趋势和范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 人工呼吸器/麻醉面罩市场分析工具
    • 波特的分析
    • PESTEL分析

第四章：人工呼吸器和麻醉面罩市场：面罩估计和趋势分析

  • 细分仪表板
  • 人工呼吸器/麻醉面罩市场：面罩波动分析，2023/2030
  • 一次性口罩
  • 可重复使用的口罩

第五章人工呼吸器和麻醉面罩市场：应用估算和趋势分析

  • 细分仪表板
  • 人工呼吸器/麻醉面罩市场：应用变化分析，2023/2030
  • 手术室
  • 加护病房
  • 急诊室
  • 居家医疗
  • ASC

第六章人工呼吸器和麻醉面罩市场：区域估计和趋势分析

  • 2023年及2030年人工呼吸器和麻醉面罩按地区市场占有率
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争格局

  • 最新趋势与影响分析：主要市场参与企业
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • GaleMed Corporation.
    • Dragerwerk AG & Co. KGaA
    • BD
    • Air Liquide Medical Systems
    • Koninklijke Philips NV
    • ResMed
    • Ambu A/S
    • VYAIRE MEDICAL, INC.
    • NIHON KOHDEN CORPORATION
    • Hamilton Medical
    • Thermo Fisher Scientific Inc.
    • Medtronic
简介目录
Product Code: 978-1-68038-709-4

Artificial Ventilation And Anesthesia Masks Market Growth & Trends:

The global artificial ventilation and anesthesia masks market size is anticipated to reach USD 3.30 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 5.1% from 2024 to 2030. Key factors attributing to market growth include rising number of operation and emergency room procedures coupled with growing demand novel products which can be used to carry out intubation process without removing the oxygen mask. Increase in the target disease has a direct impact on the number of operation room, emergency and intensive care procedures and is expected to boost usage rates of ventilation masks over the forecast period.

Increasing geriatric population is a major factor increasing the prevalence rate of several diseases. Additionally, growing prevalence of sleep apnea is one of the most significant growth drivers for these anesthesia and ventilation masks over the forecast period.

According to statistics published by the National Sleep Foundation in 2012, around 40 million Americans were affected by chronic sleep disorders. Furthermore, these patients are at a high risk of visiting emergency department and intensive care units, and as a consequence are expected to increase the demand of ventilation masks in the next seven years.

The market dynamics indicate that various players operating in this space compete on the basis of product specification and prices. The technology used to manufacture, quality of the product, and patient comfort are the key variables expected to impact the usage of these products. The healthcare providers assess the risk to the patient and determine the need to use invasive ventilation or non-invasive ventilation. The use of non invasive masks in accident and trauma cases, lung failure and other emergency cases is a key factor contributing to the high usage rates of these products.

The market is segmented on the basis of application as operation room, intensive care units, emergency room, dental, and home care. In 2014 operating room held the maximum share of over 58% for low risk procedures and is expected to be the largest segment in the next seven years. Increase in insurance penetration, number of hospitals and dental centers to tap the high unmet needs in emerging economies is a key factor expected to boost the surgical volume and therefore these factors are expected to increase the demand for ventilation masks over the forecast period.

Artificial Ventilation And Anesthesia Masks Market Report Highlights:

  • Disposable masks accounted for the largest revenue share of 68.0% in 2023. The dominance of disposable masks in the medical industry is driven by their cost-effectiveness, user convenience, reduced infection risk, and adherence to legal requirements.
  • The operating rooms application segment dominated the market with a revenue share of 32.0% in 2023. Operating rooms have modern working ventilation systems and devices for anesthesia where one is able to control in detail the amount of air circulation and the concentration of the anesthetic mixture.
  • Reusable masks are expected to grow significantly over the forecast period, registering a CAGR of 4.6%. Reusable masks offer a cost-effective solution for hospitals, as they can be cleaned and reused, reducing waste and minimizing costs.
  • North America artificial ventilation and anesthesia masks market dominated the global artificial ventilation and anesthesia masks market with a revenue share of 36.1% in 2023.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Artificial Ventilation and Anesthesia Masks Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Billion)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Artificial Ventilation and Anesthesia Masks Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Artificial Ventilation and Anesthesia Masks Market: Masks Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Artificial Ventilation and Anesthesia Masks Market: Masks Movement Analysis, 2023 & 2030 (USD Billion)
  • 4.3. Disposable Masks
    • 4.3.1. Disposable Masks Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.4. Reusable Masks
    • 4.4.1. Reusable Masks Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Artificial Ventilation and Anesthesia Masks Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Artificial Ventilation and Anesthesia Masks Market: Application Movement Analysis, 2023 & 2030 (USD Billion)
  • 5.3. Operating Rooms
    • 5.3.1. Operating Rooms Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.4. ICU
    • 5.4.1. ICU Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.5. Emergency Rooms
    • 5.5.1. Emergency Rooms Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.6. Homecare
    • 5.6.1. Homecare Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.7. ASCs
    • 5.7.1. ASCs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Artificial Ventilation and Anesthesia Masks Market: Regional Estimates & Trend Analysis

  • 6.1. Artificial Ventilation and Anesthesia Masks Market Share, By Region, 2023 & 2030 (USD Billion)
  • 6.2. North America
    • 6.2.1. North America Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.3. Europe
    • 6.3.1. Europe Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.2. UK
      • 6.3.2.1. UK Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.4. France
      • 6.3.4.1. France Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.2. China
      • 6.4.2.1. China Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.3. Japan
      • 6.4.3.1. Japan Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.4. India
      • 6.4.4.1. India Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.5. Australia
      • 6.4.5.1. Australia Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.6. South Korea
      • 6.4.6.1. South Korea Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.5. Latin America
    • 6.5.1. Latin America Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.4. UAE
      • 6.6.4.1. UAE Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Artificial Ventilation and Anesthesia Masks Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. GaleMed Corporation.
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/Strategic Initiatives
    • 7.4.2. Dragerwerk AG & Co. KGaA
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/Strategic Initiatives
    • 7.4.3. BD
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/Strategic Initiatives
    • 7.4.4. Air Liquide Medical Systems
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/Strategic Initiatives
    • 7.4.5. Koninklijke Philips N.V.
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/Strategic Initiatives
    • 7.4.6. ResMed
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/Strategic Initiatives
    • 7.4.7. Ambu A/S
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/Strategic Initiatives
    • 7.4.8. VYAIRE MEDICAL, INC.
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/Strategic Initiatives
    • 7.4.9. NIHON KOHDEN CORPORATION
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/Strategic Initiatives
    • 7.4.10. Hamilton Medical
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/Strategic Initiatives
    • 7.4.11. Thermo Fisher Scientific Inc.
      • 7.4.11.1. Participant's Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Recent Developments/Strategic Initiatives
    • 7.4.12. Medtronic
      • 7.4.12.1. Participant's Overview
      • 7.4.12.2. Financial Performance
      • 7.4.12.3. Product Benchmarking
      • 7.4.12.4. Recent Developments/Strategic Initiatives